Related Experiment Videos
[Induction of thromboplastin-like procoagulating activity by Mycoplasma pneumonia]
Giornale Di Batteriologia, Virologia Ed Immunologia
|January 1, 1986
Abstract:
The capacity of a strain of Mycoplasma pneumoniae to induce the production of procoagulant activity by human mononuclear cells is described. This finding could contribute to the understanding of the pathogenetic mechanism(s) involved in the thromboembolic complications often associated with fatal cases of Mycoplasma pneumoniae infection.
Insights
Mycoplasma pneumoniae can trigger procoagulant activity in human immune cells. This discovery aids in understanding blood clot risks in severe Mycoplasma pneumoniae infections.
Area of Science:
- Immunology
- Pathogen-host interactions
- Hematology
Context:
- Mycoplasma pneumoniae is a common respiratory pathogen.
- Severe infections are linked to thromboembolic events.
- The procoagulant effects of M. pneumoniae are not fully understood.
Purpose:
- To investigate the ability of Mycoplasma pneumoniae to induce procoagulant activity.
- To explore the role of human mononuclear cells in this response.
- To elucidate potential mechanisms behind M. pneumoniae-associated thrombosis.
Summary:
- A specific strain of Mycoplasma pneumoniae was shown to induce procoagulant activity.
- Human mononuclear cells were identified as key players in this response.
- This interaction involves the activation of the coagulation cascade.
Impact:
- Provides insights into the pathogenesis of thromboembolic complications in Mycoplasma pneumoniae infections.
- Highlights a potential mechanism linking M. pneumoniae to blood clot formation.
- Offers a basis for further research into diagnostic and therapeutic strategies.